PHASE I AND PHARMACOKINETIC TRIAL OF PTC299 IN PEDIATRIC PATIENTS WITH REFRACTORY OR RECURRENT CNS TUMORS: A PBTC STUDY

被引：0
|
作者：
Packer, Roger J. [1 ]
Rood, Brian R. [1 ]
Onar-Thomas, Arzu [2 ]
Goldman, Stewart [3 ]
Fisher, Michael J. [4 ]
Smith, Christopher [2 ]
Boyett, James [2 ]
Kun, Larry [2 ]
机构：
[1] Childrens Natl Med Ctr, Washington, DC 20010 USA
[2] St Jude Childrens Res Hosp, Memphis, TN 38105 USA
[3] Childrens Mem Hosp, Chicago, IL 60614 USA
[4] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
来源：
NEURO-ONCOLOGY | 2012年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：112 / 112
页数：1
相关论文
共 50 条
  • [21] Phase I clinical trial of cilengitide in children with refractory brain tumors: Pediatric brain tumor consortium study PBTC-012
    MacDonald, Tobey J.
    Stewart, Clinton F.
    Kocak, Mehmet
    Goldman, Stewart
    Ellenbogen, Richard G.
    Phillips, Peter
    Lafond, Deborah
    Poussaint, Tina Young
    Kieran, Mark W.
    Boyett, James M.
    Kun, Larry E.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (06) : 919 - 924
  • [22] Phase I Study of Bevacizumab Plus Irinotecan in Pediatric Patients with Recurrent/Refractory Solid Tumors
    Okada, Keiko
    Yamasaki, Kai
    Tanaka, Chika
    Fujisaki, Hiroyuki
    Osugi, Yuko
    Hara, Junichi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2013, 43 (11) : 1073 - 1079
  • [23] A PHASE I STUDY ON CABOZANTINIB MONOTHERAPY IN PEDIATRIC PATIENTS WITH RECURRENT AND/OR REFRACTORY SOLID TUMORS (CAMEL STUDY)
    Nakajima, Miho
    Tao, Kayoko
    Kimura, Toshimi
    Ogawa, Chitose
    Arakawa, Ayumu
    PEDIATRIC BLOOD & CANCER, 2022, 69
  • [24] A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study
    Banerjee, Anuradha
    Jakacki, Regina I.
    Onar-Thomas, Arzu
    Wu, Shengjie
    Nicolaides, Theodore
    Poussaint, Tina Young
    Fangusaro, Jason
    Phillips, Joanna
    Perry, Arie
    Turner, David
    Prados, Michael
    Packer, Roger J.
    Qaddoumi, Ibrahim
    Gururangan, Sridharan
    Pollack, Ian F.
    Goldman, Stewart
    Doyle, Lawrence A.
    Stewart, Clinton F.
    Boyett, James M.
    Kun, Larry E.
    Fouladi, Maryam
    NEURO-ONCOLOGY, 2017, 19 (08) : 1135 - 1144
  • [25] Phase I trial of VNP40101M in children with recurrent brain tumors-A Pediatric Brain Tumor Consortium (PBTC) study
    Gururangan, S.
    Turner, C.
    Stewart, C. F.
    Kocak, M.
    Poussaint, T. Y.
    Boyett, J. M.
    Kun, L. E.
    Karsten, V.
    Gerson, S. L.
    Friedman, H. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [26] PHASE-I CLINICAL AND PHARMACOKINETIC STUDY OF BISANTRENE IN REFRACTORY PEDIATRIC SOLID TUMORS
    PRATT, CB
    SINKULE, JA
    ETCUBANAS, E
    DOUGLASS, EC
    CROM, DB
    CHOI, K
    AVERY, L
    INVESTIGATIONAL NEW DRUGS, 1986, 4 (02) : 149 - 153
  • [27] Phase I study of tamibarotene monotherapy in pediatric and young adult patients with recurrent/refractory solid tumors
    Chika Nitani
    Junichi Hara
    Hiroshi Kawamoto
    Tomoaki Taguchi
    Toshimi Kimura
    Kenichi Yoshimura
    Akinobu Hamada
    Shigehisa Kitano
    Naoko Hattori
    Toshikazu Ushijima
    Hiromi Ono
    Masako Nakamoto
    Tsukiko Higuchi
    Akihiro Sato
    Cancer Chemotherapy and Pharmacology, 2021, 88 : 99 - 107
  • [28] Phase I study of tamibarotene monotherapy in pediatric and young adult patients with recurrent/refractory solid tumors
    Nitani, Chika
    Hara, Junichi
    Kawamoto, Hiroshi
    Taguchi, Tomoaki
    Kimura, Toshimi
    Yoshimura, Kenichi
    Hamada, Akinobu
    Kitano, Shigehisa
    Hattori, Naoko
    Ushijima, Toshikazu
    Ono, Hiromi
    Nakamoto, Masako
    Higuchi, Tsukiko
    Sato, Akihiro
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2021, 88 (01) : 99 - 107
  • [29] A phase I trial and pharmacokinetic study of IMC-A12 in pediatric patients with relapsed/refractory solid tumors: A Children's Oncology Group Phase I Consortium study
    Malempati, S.
    Weigel, B.
    Ingle, A. M.
    Ahern, C. H.
    Carroll, J. M.
    Roberts, C. T., Jr.
    Fox, F. E.
    Voss, S.
    Adamson, P. C.
    Blaney, S. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [30] A phase I/II study of lenvatinib (LEN) plus everolimus (EVE) in recurrent and refractory pediatric solid tumors, including CNS tumors.
    Dela Cruz, Filemon S.
    Fox, Elizabeth
    Muscal, Jodi Ann
    Kirov, Ivan
    Geller, James I.
    DuBois, Steven G.
    Kim, AeRang
    Croop, James
    Laetsch, Theodore Willis
    Minard, Charles G.
    Liu, Xiaowei
    Weigel, Brenda
    Okpara, Chinyere E.
    Huang, Jie
    Dutta, Lea
    Aluri, Jagadeesh
    Bender, Julia Lynne Glade
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345